Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses [Phase 3]

View source ↗

Summary

This Phase 3 study evaluating the efficacy and safety of Actikerall Solution for grade I-II actinic keratoses has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Actikerall (5-fluorouracil topical solution)

Snippet

Sponsor: Almirall, S.A. | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED